Gut Microbiota and Down’s Syndrome: a Relationship Beginning to Emerge

In recent years, research on the gut microbiota — the community of microorganisms that inhabit our intestines — has advanced remarkably. Today, we know that these microbial communities influence processes as diverse as digestion, the immune system, inflammation, and even brain function.
But what happens in the case of Down’s syndrome (DS)?

Why talk about the microbiota in Down’s syndrome?

Down’s syndrome is a genetic condition characterised by the presence of an extra copy of chromosome 21. Although its clinical manifestations are varied, many of the associated health challenges relate to:

• Alterations in the immune system

• Higher prevalence of coeliac disease, thyroid disorders, and gastrointestinal issues

• Metabolic changes

• Increased risk of low-grade chronic inflammation

All these aspects are closely linked to the gut microbiota, which has led scientists to investigate how the microbiota of people with DS differs from that of the general population.

What do studies show?

Although research is still limited, several characteristic patterns have been observed:

Reduced microbial diversity

Diversity is generally associated with a more robust and healthier microbiota. In DS, a slightly lower biodiversity has been reported.

Increased presence of pro-inflammatory bacteria

Some studies indicate a rise in microbes associated with inflammatory processes. This may be related to the baseline inflammatory state often observed in DS.

Lower abundance of beneficial bacteria

Reduced levels of short-chain fatty acid–producing genera, such as Faecalibacterium, have been detected. These bacteria have anti-inflammatory effects and help protect the intestinal mucosa.

Links with cognitive function and the gut–brain axis

The microbiota influences neurotransmitter production, oxidative stress, and inflammation. Some researchers are exploring whether these microbial differences may contribute to certain neurocognitive characteristics of DS.

What are the implications?

Understanding the microbiota in people with Down’s syndrome opens the door to:

Personalised nutritional interventions

Fibre-rich diets, fermented foods, and probiotic strategies could help modulate the microbiota.

Better immune system management

A balanced microbiota may help reduce inflammation and improve immune responses.

Support for digestive health

This is particularly relevant due to the higher frequency of intolerances, coeliac disease, and constipation.

What lies ahead

There are still no microbiota-based recommendations specifically for Down’s syndrome, but research is growing rapidly. In the coming years, we may see:

• Probiotics designed for microbial profiles characteristic of DS

• Microbial biomarkers to anticipate metabolic or immunological risks

• Personalised therapies based on the gut–brain axis

Conclusion

The gut microbiota is a key component in the comprehensive understanding of Down’s syndrome. Although much remains to be discovered, current evidence points to a deep connection between the gut, the immune system, and the brain.
Caring for the microbiota — through diet, lifestyle, and advanced research — may become a valuable tool for improving the quality of life of people with DS.